Original Research
Published on 26 Sep 2018
Ibrutinib Resistance Is Reduced by an Inhibitor of Fatty Acid Oxidation in Primary CLL Lymphocytes
in Molecular and Cellular Oncology

- 5,966 views
- 28 citations
Original Research
Published on 26 Sep 2018
in Molecular and Cellular Oncology

Editorial
Published on 26 Sep 2018
in Molecular and Cellular Oncology
Review
Published on 21 Sep 2018
in Molecular and Cellular Oncology

Review
Published on 11 Sep 2018
in Molecular and Cellular Oncology

Hypothesis and Theory
Published on 10 Sep 2018
in Molecular and Cellular Oncology
Review
Published on 10 Sep 2018
in Molecular and Cellular Oncology

Brief Research Report
Published on 07 Sep 2018
in Molecular and Cellular Oncology

Original Research
Published on 05 Sep 2018
in Molecular and Cellular Oncology

Opinion
Published on 04 Sep 2018
in Molecular and Cellular Oncology

Review
Published on 04 Sep 2018
in Molecular and Cellular Oncology

Original Research
Published on 04 Sep 2018
in Molecular and Cellular Oncology

Mini Review
Published on 30 Aug 2018
in Molecular and Cellular Oncology

Review
Published on 28 Aug 2018
in Molecular and Cellular Oncology

Perspective
Published on 28 Aug 2018
in Molecular and Cellular Oncology

Review
Published on 28 Aug 2018
in Molecular and Cellular Oncology

Review
Published on 28 Aug 2018
in Molecular and Cellular Oncology
